干细胞标志Nanog在食管鳞癌组织中表达及预后关系(3)
[4]史亚飞,曹明智.乳腺癌干细胞的研究进展[J].中华肿瘤防治杂志,2009,16(22):1814-1817.
[5]朱峰,王敏,秦仁义,等.人胰腺癌干细胞对吉西他滨的敏感性及其分子机制研究[J].华中科技大学学报:医学版,2010,39(3):281-287.
[6]Yang ZF,Ho DW,Ng MN,et al.Significance of CD90+ cancer stem cells in human liver cancer[J]. Cancer Cell,2008,13(2):153-166.
[7]李亚卓,赵坡.SGC-7901和MGC-803肿瘤干细胞中不同分子标志表达的观察[J].中华肿瘤防治杂志,2009,16(3):167-171.
[8]Mitsui K,Tokuzawa Y,Itoh H,et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells[J].Cell,2003,113(5):631-642.
[9]Schwarz-Cruz-y-Celis A, Meléndez-Zajgla J. Cancer stem cells[J].Rev Invest Clin, 2011, 63(2):179-186.
[10]You J S,Kang J K,Seo D W,et al. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression[J].Cancer Res,2009,69( 14) : 5716 -5725.
[11]Jcter C R,Badeanx M,ChoY C,et al. Functional evidence that the self - renewal gene NANOG regulates human tumor development[J]. Stem Cells,2009,27(5):993 -1005.
[12]余宏,張昌明,吴永寿.肿瘤干细胞及其耐药性的研究进展[J].癌症,2010,29(3):279-283. 编辑/罗茗柯, 百拇医药(麻成方 余征 李绍鹏 李志华 魏春勇 汪礼旭 洪琼川)
[5]朱峰,王敏,秦仁义,等.人胰腺癌干细胞对吉西他滨的敏感性及其分子机制研究[J].华中科技大学学报:医学版,2010,39(3):281-287.
[6]Yang ZF,Ho DW,Ng MN,et al.Significance of CD90+ cancer stem cells in human liver cancer[J]. Cancer Cell,2008,13(2):153-166.
[7]李亚卓,赵坡.SGC-7901和MGC-803肿瘤干细胞中不同分子标志表达的观察[J].中华肿瘤防治杂志,2009,16(3):167-171.
[8]Mitsui K,Tokuzawa Y,Itoh H,et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells[J].Cell,2003,113(5):631-642.
[9]Schwarz-Cruz-y-Celis A, Meléndez-Zajgla J. Cancer stem cells[J].Rev Invest Clin, 2011, 63(2):179-186.
[10]You J S,Kang J K,Seo D W,et al. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression[J].Cancer Res,2009,69( 14) : 5716 -5725.
[11]Jcter C R,Badeanx M,ChoY C,et al. Functional evidence that the self - renewal gene NANOG regulates human tumor development[J]. Stem Cells,2009,27(5):993 -1005.
[12]余宏,張昌明,吴永寿.肿瘤干细胞及其耐药性的研究进展[J].癌症,2010,29(3):279-283. 编辑/罗茗柯, 百拇医药(麻成方 余征 李绍鹏 李志华 魏春勇 汪礼旭 洪琼川)